Mr. Turner is cofounder and Executive Chair of Onchilles and is a Partner at LYZZ Capital Advisors. Mr. Turner has more than 25 years of experience in founding, operating, fundraising for, and exiting life science companies. LYZZ currently has six (6) portfolio companies in the San Diego biotech community. Prior to co-founding Onchilles with Dr. Lev Becker, Mr. Turner was a venture partner at Avalon Ventures for a decade. During his time at Avalon, he was as the founding CEO and director of Synthorx, Inc. (acquired by Sanofi) and founding chairman and CEO of RQx Pharmaceuticals (transaction with Genentech). Before Avalon, he served as a member of the executive management teams at Kalypsys, Inc. and Aurora Biosciences (acquired by Vertex Pharmaceuticals). Mr. Turner received his J.D. from the University of San Diego School of Law and a B.S. in psychology from San Diego State University.